Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Stem Cell Market: By Product Type: Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others; By Treatment Type: Allogeneic Stem Cell Therapy, Others; By Application; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Stem Cell Market Outlook
The global stem cell market attained a value of about USD 14.5 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 10.3% to reach nearly USD 26.1 billion by 2026.
Rising Prevalence of Regenerative Medicines Boosting the Market Growth of Stem Cell
The increasing activities to use stem cells in regenerative medicines owing to their therapeutic properties are augmenting the growth of the stem cell industry. The growing utilisation of human-induced pluripotent stem cells (iPSCs) for the treatment of various inherited heart complications, neurological disorders, and genetic diseases like recessive dystrophic epidermolysis bullosa (RBED) is significantly contributing to the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Moreover, human-induced pluripotent stem cells (iPSCs) can eliminate immunosuppression, due to which they function as a significant source of cells for autologic stem cell therapy, therefore bolstering the industry growth. In addition, the increasing incentives provided by the leading companies to deliver breakthrough therapy for stem cells to surge the utilisation of advanced resources and tools in research and development activities (R&D) is providing impetus to the market growth of stem cell.
North America to Hold a Significant Share of the Stem Cell Industry
North America accounts for a considerable share of the overall stem cell industry owing to the increasing research and development (R&D) in the United States and Canada. Moreover, the rising prevalence of non-communicable chronic diseases, such as cancer and Parkinson’s, among others, is surging the deployment of stem cell treatment, which is strengthening the industry growth. Moreover, the robust healthcare sector in the region is increasing the accessibility for advanced cell therapy treatments, hence aiding the growth of the regional stem cell industry. Apart from this, the Asia Pacific region is expected to grow rapidly due to the rising use of regenerative medicines. Moreover, surging clinical trials owing to cheap labour costs and the availability of raw materials in the region is aiding the market growth, therefore significantly contributing to the overall industry growth.
Stem Cell: Industry Definition and Segmentation
A stem cell is a cell that can develop various cells ranging from brain cells to muscle cells. It can also aid in fixing damaged tissues. As stem cells have the potential to treat various non-communicable and chronic diseases, such as Alzheimer’s and diabetes, among others, they are employed in various medical and biotechnological research activities to repair tissue damage caused by diseases.
The major product types of stem cell are:
- Adult Stem Cell
- Human Embryonic Cell
- Pluripotent Stem Cell
- Others
The market can be broadly categorised on the basis of its treatment types into:
- Allogeneic Stem Cell Therapy
- Autologic Stem Cell Therapy
- Syngeneic Stem Cell Therapy
Based on applications, the market is divided into:
- Neurological Disorders
- Orthopaedic Treatments
- Oncology Disorders
- Injuries and Wounds
- Cardiovascular Disorders
- Others
The EMR report looks into the regional markets of stem cell like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Technological Advancements to Bolster the Market Growth of Stem Cell
Increasing research activities in regenerative medicines and biotechnology to personalise stem cell therapy is anticipated to propel the market growth. The rising demand for treatment of prevalent issues, such as age-related macular degeneration (AMD), among the growing geriatric population is expected to increase the use of stem cells. As each cell posits individual characteristics, it becomes very difficult to characterise cell products due to various error bars during research activities. This is consequently surging the integration of the latest technologies, such as artificial intelligence (AI), blockchain, and machine learning. The use of artificial intelligence (AI) to rapidly analyse images, predict cell functions, and classify tissues to identify cell products, which is estimated to augment the market growth.
The increasing prevalence of cancer and cancer-related research projects is increasing the use of blockchain technology to collect and assimilate data to enhance the accessibility to clinical results and the latest developments. Blockchain can also aid in storing patients’ data efficiently while enhancing the cost-effectiveness of cord-blood banking for advanced research and development (R&D) activities. Moreover, the integration of machine learning algorithms to analyse images and infer the correlation between cellular structures is bolstering the market growth. The growing interest in comprehending processes at a cellular level and identify crucial processes using deep learning is projected to propel the growth of the stem cell industry.
Key Industry Players in the Global Stem Cell Market
The report presents a detailed analysis of the following key players in the global stem cell market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Pluristem Therapeutics Inc.
- Thermo Fisher Scientific Inc.
- Cellular Engineering Technologies
- Merck KGaA
- Becton, Dickinson and Company
- STEMCELL Technologies Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type, Treatment Type, Application, Region |
| Breakup by Product Type | Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others |
| Breakup by Treatment Type | Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy |
| Breakup by Application | Neurological Disorders, Orthopaedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Pluristem Therapeutics Inc., Thermo Fisher Scientific Inc., Cellular Engineering Technologies, Merck KGaA, Becton, Dickinson and Company, STEMCELL Technologies Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Stem Cell Market Analysis
8.1 Key Industry Highlights
8.2 Global Stem Cell Historical Market (2016-2020)
8.3 Global Stem Cell Market Forecast (2021-2026)
8.4 Global Stem Cell Market by Product Type
8.4.1 Adult Stem Cell
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Human Embryonic Cell
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Pluripotent Stem Cell
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Others
8.5 Global Stem Cell Market by Treatment Type
8.5.1 Allogeneic Stem Cell Therapy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Autologic Stem Cell Therapy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Syngeneic Stem Cell Therapy
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.6 Global Stem Cell Market by Application
8.6.1 Neurological Disorders
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Orthopaedic Treatments
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Oncology Disorders
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Injuries and Wounds
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2016-2020)
8.6.4.3 Forecast Trend (2021-2026)
8.6.5 Cardiovascular Disorders
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2016-2020)
8.6.5.3 Forecast Trend (2021-2026)
8.6.6 Others
8.7 Global Stem Cell Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Pluristem Therapeutics Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Thermo Fisher Scientific Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Cellular Engineering Technologies
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Merck KGaA
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Becton, Dickinson and Company
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 STEMCELL Technologies Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Stem Cell Market: Key Industry Highlights, 2016 and 2026
2. Global Stem Cell Historical Market: Breakup by Product Type (USD Million), 2016-2020
3. Global Stem Cell Market Forecast: Breakup by Product Type (USD Million), 2021-2026
4. Global Stem Cell Historical Market: Breakup by Treatment Type (USD Million), 2016-2020
5. Global Stem Cell Market Forecast: Breakup by Treatment Type (USD Million), 2021-2026
6. Global Stem Cell Historical Market: Breakup by Application (USD Million), 2016-2020
7. Global Stem Cell Market Forecast: Breakup by Application (USD Million), 2021-2026
8. Global Stem Cell Historical Market: Breakup by Region (USD Million), 2016-2020
9. Global Stem Cell Market Forecast: Breakup by Region (USD Million), 2021-2026
10. North America Stem Cell Historical Market: Breakup by Country (USD Million), 2016-2020
11. North America Stem Cell Market Forecast: Breakup by Country (USD Million), 2021-2026
12. Europe Stem Cell Historical Market: Breakup by Country (USD Million), 2016-2020
13. Europe Stem Cell Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Asia Pacific Stem Cell Historical Market: Breakup by Country (USD Million), 2016-2020
15. Asia Pacific Stem Cell Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Latin America Stem Cell Historical Market: Breakup by Country (USD Million), 2016-2020
17. Latin America Stem Cell Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Middle East and Africa Stem Cell Historical Market: Breakup by Country (USD Million), 2016-2020
19. Middle East and Africa Stem Cell Market Forecast: Breakup by Country (USD Million), 2021-2026
20. Global Stem Cell Market Structure
Key Questions Answered in the Report
In 2020, the global stem cell market attained a value of nearly USD 14.5 billion.
The market is projected to grow at a CAGR of 0.103% between 2021 and 2026.
The market is estimated to witness healthy growth in the forecast period of 2021-2026 to reach about USD 26.1 billion by 2026.
The market is being aided by the rising prevalence of various non-communicable diseases, the increasing investments in stem cell therapies, and the growing utilisation of human-induced pluripotent stem cells (iPSCs).
The market is expected to be driven by the increasing research activities in regenerative medicines, the treatment of various health-related issues through cell therapy, and the integration of the latest technologies in research and development (R&D) activities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major product types of stem cell in the industry are adult stem cell, human embryonic cell, and pluripotent stem cell, among others.
The significant treatment types in the market are allogeneic stem cell therapy, autologic stem cell therapy, and syngeneic stem cell therapy.
The various applications of stem cell are neurological disorders, orthopaedic treatments, oncology disorders, injuries and wounds, and cardiovascular disorders, among others.
The major players in the industry are Pluristem Therapeutics Inc., Thermo Fisher Scientific Inc., Cellular Engineering Technologies, Merck KGaA, Becton, Dickinson and Company, and STEMCELL Technologies Inc., among others.
Analyst Review
The global stem cell market attained a value of nearly USD 14.5 billion in 2020, driven by the rising prevalence of various non-communicable diseases. Aided by the integration of the latest technologies in research and development (R&D) activities, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 10.3%. The market is projected to reach about USD 26.1 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product types, the stem cell industry can be segmented into adult stem cell, human embryonic cell, and pluripotent stem cell, among others. On the basis of treatment types, the industry is divided into allogeneic stem cell therapy, autologic stem cell therapy, and syngeneic stem cell therapy. By applications, the market is categorised into neurological disorders, orthopaedic treatments, oncology disorders, injuries and wounds, and cardiovascular disorders, among others. The major regional markets for stem cell are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pluristem Therapeutics Inc., Thermo Fisher Scientific Inc., Cellular Engineering Technologies, Merck KGaA, Becton, Dickinson and Company, and STEMCELL Technologies Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global cancer immunotherapy market stood at a value of around USD 86,607 million in 2020. The market is further expected to grow at a CAGR of 9.7% in the forecast period of 2021-2026 to attain a v...
The global sickle cell disease treatment market stood at a value of around USD 3.4 billion in 2020. The market is further expected to grow at a CAGR of 16.9% in the forecast period of 2021-2026 to att...
The global dry eye disease treatment market attained a value of nearly USD 5 billion in 2020, driven by the rising prevalence of eye complications among the growing geriatric population. Aided by the ...
The global polymyalgia rheumatica treatment market attained a value of nearly USD 177 million in 2020, driven by the introduction of various clinical programs. Aided by the growing demand for physical...
The global haematologic malignancies treatment market attained a value of USD 52.1 billion in 2020, driven by the rising prevalence of hematologic malignancies. Aided by the increasing R&D investment,...
NEWSLETTER